Application 081319
- Type
- ANDA
- Sponsor
- AKORN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PYRAZINAMIDE | PYRAZINAMIDE | TABLET;ORAL | 500MG | No | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50090-0520 | Pyrazinamide | Pyrazinamide | A-S Medication Solutions | ANDA | Current |
| 50090-0520 | Pyrazinamide | Pyrazinamide | A-S Medication Solutions | ANDA | Current |
| 50090-0520 | Pyrazinamide | Pyrazinamide | A-S Medication Solutions | ANDA | Current |
| 55695-026 | Pyrazinamide | Pyrazinamide | Department of State Health Services, Pharmacy Branch | ANDA | Current |
| 61748-012 | Pyrazinamide | Pyrazinamide | VersaPharm Inc. - an Akorn Company | ANDA | Current |
| 61748-012 | Pyrazinamide | Pyrazinamide | Versapharm Incorporated | ANDA | Current |
| 61748-012 | Pyrazinamide | Pyrazinamide | Akorn | ANDA | Current |
| 70518-2534 | Pyrazinamide | Pyrazinamide | REMEDYREPACK INC. | ANDA | Current |
| 70518-2534 | Pyrazinamide | Pyrazinamide | REMEDYREPACK INC. | ANDA | Current |